
About Enzon
Enzon is a company based in Bridgewater (United States) founded in 1981. Enzon offers products and services including Acquisition Services and Investor Relations.
- Annual Revenue$26 K (USD)0as on Dec 31, 2024
- Net Profit$778 K (USD)-43.34as on Dec 31, 2024
- EBITDA-$1.33 M (USD)-27.11as on Dec 31, 2024
Products & Services of Enzon
Enzon offers a comprehensive portfolio of products and services, including Acquisition Services and Investor Relations.
Acquisition services are provided as a vehicle for public companies
Investor relations are managed to enhance stockholder value through strategic initiatives
IPO & Listings of Enzon
Enzon is a publicly listed company on the OTC with ticker symbol ENZN in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date17 Feb 1984
- Listed onOTCMKTS: ENZN
- Listed entityEnzon Pharmaceuticals, Inc.
- Exchange sectorHealth technology
- ISINUS2939041081
- Share price$6.10 (-0.15% on the day) · 2026-05-11
- Market capitalisation$87.4M
- EPS (diluted, trailing year)$-6.88
- Volume (last session)623
- Analyst consensusNo rating
Financials of Enzon
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2024 | $26,000 | $778,000 | -$1.3M |
| 2023 | – | $1.4M | -$1.0M |
| 2022 | $26,000 | -$186,000 | -$1.0M |
| 2021 | $701,000 | -$469,000 | -$469,000 |
| 2020 | $52,000 | -$1.3M | -$1.3M |
Detailed financial statements for Enzon
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of Enzon
The website of Enzon (enzon.com) receives about 1.4K visits a month and ranks #8,914,161 among all websites worldwide, #7,531 in Biotechnology and Pharmaceuticals.
- Monthly visits1.4K
▼ 16.1% vs previous month
- Global rank#8,914,161
among all websites
- Category rank#7,531
Health · Biotechnology and Pharmaceuticals
- Bounce rate38%
- Pages per visit1.8
- Average visit40 sec
- DevicesDesktop 26% Β· Mobile 74%
Websites whose visitors overlap most with Enzon. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| endo.com | 100% | 10K | #2,323,439 | View details | |
activery.com | activery.com | 100% | – | – | β |
| smblab.be | 100% | – | – | View details | |
| biocydex.net | 100% | – | – | View details | |
| gelscom.com | 100% | – | – | View details | |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 18 similar websites and full traffic analytics for Enzon
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 18 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Enzon
Complete news archive for Enzon
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Enzon
10 companies that operate in the same segment as Enzon (Traditional Health & Nutrition), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Manufacturer of generics formulations | 2002 | Bridgewater, New Jersey, United States | – | USD 3.02 B | 8,300 | |
Biosimilar therapeutics are developed for oncology and autoimmune diseases. | 2010 | Redwood City, California, United States | USD 143.62 M | USD 42.17 M | 228 | |
Oral solid drug delivery systems are manufactured and developed. | 1985 | Mumbai, Maharashtra, India | USD 42.49 M | USD 89.42 M | 962 | |
Ophthalmic pharmaceuticals and instruments are developed for eye care. | 1853 | Bridgewater, New Jersey, United States | – | USD 5.1 B | 13,500 | |
Generic pharmaceuticals are manufactured by Teva Pharmaceuticals. | 1901 | Petah Tikva, Central District, Israel | USD 500 M | USD 18.74 B | 51,792 | |
Generic, semi-solid, and liquid dosage forms are manufactured. | 1990 | Bengaluru, Karnataka, India | – | USD 508.93 M | 5,180 | |
Pharmaceutical products are developed and marketed globally. | 2009 | Montville, New Jersey, United States | USD 155.92 M | – | – | |
Specialty generic pharmaceuticals and APIs are manufactured and marketed. | 1983 | Mumbai, Maharashtra, India | – | USD 6.21 B | 25,870 | |
Pharmaceutical company engaged in developing, manufacturing, and marketing a diverse range of pharmaceutical formulations | 1991 | Delhi, Delhi, India | USD 367.2 M | USD 1.52 B | 21,320 | |
Generics, biosimilars, APIs, and vaccines are manufactured by Wockhardt. | 1967 | Mumbai, Maharashtra, India | – | USD 353.53 M | 3,410 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Enzon
Enzon was founded in 1981.
Enzon is headquartered in Bridgewater, United States. It is registered at Bridgewater, New Jersey, United States.
Annual revenue of Enzon is $26K as on Dec 31, 2024.
Enzon was founded in 1981 and operates as a public acquisition vehicle in the financial sector, based in Bridgewater, United States. Net operating loss carryforwards are leveraged to acquire and integrate businesses, with the aim of maximizing these tax assets for shareholder benefit. The platform focuses on strategic acquisitions that enhance returns through tax efficiency and operational synergies.
Enzon offers Acquisition Services and Investor Relations.
Yes, Enzon is publicly traded on OTC under the ticker symbol ENZN.
Enzon operates through Enzon Pharmaceuticals, Inc.
